We also found that exosomal miR-29a could upregulate certain memory/synaptic plasticity-related genes via targeting the histone-modifying enzyme, histone deacetylase 4 (HDAC4), suggesting that HDAC4 might be a critical molecule for AD diagnosis and treatment. The gene discussed is HDAC4; the disease is Alzheimer disease.